Michael W. Ong

501 Smyth Road
Ottawa, ON, Canada

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 69 publications

Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir.

Outcomes of a Canadian real-world cohort of metastatic castration-sensitive prostate cancer patients stratified by early PSA nadir.

Journal: Future oncology (London, England)

Published: June 19, 2026

How will PLUDO, PSMAfore, SPLASH, and ECLIPSE Impact Prostate Cancer Management?

How will PLUDO, PSMAfore, SPLASH, and ECLIPSE Impact Prostate Cancer Management?

Journal: European urology focus

Published: May 29, 2026

Genetic testing practices among specialist physicians who treat prostate cancer: Updated survey of Canadian practitioners.

Genetic testing practices among specialist physicians who treat prostate cancer: Updated survey of Canadian practitioners.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: April 06, 2026

Genetic testing practices among specialist physicians who treat prostate cancer Updated survey of Canadian practitioners.

Genetic testing practices among specialist physicians who treat prostate cancer Updated survey of Canadian practitioners.

Journal: Canadian Urological Association journal = Journal de l'Association des urologues du Canada

Published: April 06, 2026

Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis.

Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis.

Journal: Current oncology (Toronto, Ont.)

Published: February 24, 2026

Use of concomitant G-CSF in maintaining efficacious dose and safe delivery of docetaxel in combination with darolutamide in ARASENS: A phase III study.

Use of concomitant G-CSF in maintaining efficacious dose and safe delivery of docetaxel in combination with darolutamide in ARASENS: A phase III study.

Journal: European journal of cancer (Oxford, England : 1990)

Published: November 24, 2025

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Prospective multicenter study of ctDNA versus tumor tissue guiding FGFR-targeted therapy in metastatic urothelial cancer.

Journal: Nature communications

Published: October 09, 2025

Canadian Prostate Cancer Trends in the Context of PSA Screening Guideline Changes.

Canadian Prostate Cancer Trends in the Context of PSA Screening Guideline Changes.

Journal: Current oncology (Toronto, Ont.)

Published: October 02, 2025

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.

Early favorable prostate-specific antigen response prediction in metastatic hormone sensitive prostate cancer.

Journal: Nature communications

Published: May 20, 2025

Association of patient and physician characteristics with androgen-deprivation-therapy intensification in patients with de novo hormone-sensitive metastatic prostate cancer: A population-based study.

Association of patient and physician characteristics with androgen-deprivation-therapy intensification in patients with de novo hormone-sensitive metastatic prostate cancer: A population-based study.

Journal: Cancer

Published: May 17, 2025

Two case reports of eosinophilic fasciitis with onset after immune checkpoint inhibitor cessation.

Two case reports of eosinophilic fasciitis with onset after immune checkpoint inhibitor cessation.

Journal: Frontiers in oncology

Published: April 16, 2025

Lessons from TROPiCS-04: 'safety-first' for success in late-stage clinical trials.

Lessons from TROPiCS-04: 'safety-first' for success in late-stage clinical trials.

Journal: Annals of oncology : official journal of the European Society for Medical Oncology

Published: February 08, 2025

Showing 1-12 of 69

Last Updated: 09/26/2026